AlphaCentric Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-82,000	Closed	-$2.44M	–	241
2023 Q3	$2.44M	Buy	82,000 +35,000	+74%	+$1.04M	1.38%	19
2023 Q2	$847K	Buy	+47,000	New	+$847K	0.47%	73